Tokai Pharmaceuticals Current Ratio 2013-2018 | NVUS

Tokai Pharmaceuticals current ratio from 2013 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Tokai Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.02B $0.00B 10.67
2018-06-30 $0.02B $0.00B 14.52
2018-03-31 $0.02B $0.00B 14.84
2017-12-31 $0.02B $0.00B 13.19
2017-09-30 $0.02B $0.00B 9.12
2017-06-30 $0.03B $0.00B 7.86
2017-03-31 $0.03B $0.00B 10.60
2016-12-31 $0.00B $0.00B 0.30
2016-09-30 $0.04B $0.01B 5.73
2016-06-30 $0.05B $0.01B 5.91
2016-03-31 $0.06B $0.01B 9.23
2015-12-31 $0.07B $0.01B 10.90
2015-09-30 $0.08B $0.01B 13.59
2015-06-30 $0.09B $0.01B 18.67
2015-03-31 $0.10B $0.01B 16.74
2014-12-31 $0.11B $0.00B 25.34
2014-09-30 $0.11B $0.01B 19.87
2014-06-30 $0.02B $0.00B 5.90
2014-03-31 $0.00B $0.00B 0.00
2013-12-31 $0.00B $0.00B 0.00
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2012-12-31 $0.01B $0.00B 5.93
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.035B $0.000B
Novus Therapeutics, Inc. is a pharmaceutical company. It focused on the acquisition, development and commercialization of ear, nose and throat products. The company's platform consists of OP-01 Foam Platform and OP-02 Surfactant Program. Novus Therapeutics, Inc., formerly known as Tokai Pharmaceuticals Inc., is based in Irvine, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.398B 30.86
Takeda Pharmaceutical (TAK) Japan $33.153B 12.27
Grifols (GRFS) Spain $13.201B 16.00
Ionis Pharmaceuticals (IONS) United States $10.870B 34.75
Jazz Pharmaceuticals (JAZZ) Ireland $7.800B 11.17
Neurocrine Biosciences (NBIX) United States $7.664B 496.41
Sage Therapeutics (SAGE) United States $7.450B 0.00
Tilray (TLRY) United States $6.754B 0.00
Nektar Therapeutics (NKTR) United States $6.186B 9.87
Catalent (CTLT) United States $6.146B 25.73
United Therapeutics (UTHR) United States $5.149B 8.76
FibroGen (FGEN) United States $4.834B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.238B 13.64
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.164B 0.00
Portola Pharmaceuticals (PTLA) United States $2.224B 0.00
Zogenix (ZGNX) United States $2.190B 0.00
USANA Health Sciences (USNA) United States $2.146B 18.01
Aerie Pharmaceuticals (AERI) United States $2.135B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.134B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.106B 0.00
PTC Therapeutics (PTCT) United States $2.103B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.968B 24.51
Endo (ENDP) Ireland $1.894B 2.92
Heron Therapeutics (HRTX) United States $1.853B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.754B 0.00
Xencor (XNCR) United States $1.688B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.592B 137.93
Corcept Therapeutics (CORT) United States $1.396B 20.28
Esperion Therapeutics (ESPR) United States $1.338B 0.00
TherapeuticsMD (TXMD) United States $1.317B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.276B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.108B 0.00
Tricida (TCDA) United States $1.047B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.888B 0.00
Radius Health (RDUS) United States $0.854B 0.00
Odonate Therapeutics (ODT) United States $0.635B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.602B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Collegium Pharmaceutical (COLL) United States $0.566B 0.00
Forty Seven (FTSV) United States $0.552B 0.00
GlycoMimetics (GLYC) United States $0.522B 0.00
ChemoCentryx (CCXI) United States $0.515B 0.00
ArQule (ARQL) United States $0.510B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.504B 29.73
Siga Technologies (SIGA) United States $0.503B 0.00
KalVista Pharmaceuticals (KALV) United States $0.499B 0.00
Akebia Therapeutics (AKBA) United States $0.466B 0.00
Flexion Therapeutics (FLXN) United States $0.456B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.431B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.405B 0.00
TCR2 THERAPTCS (TCRR) United States $0.402B 0.00
ImmunoGen (IMGN) United States $0.396B 0.00
Concert Pharmaceuticals (CNCE) United States $0.388B 0.00
OptiNose (OPTN) United States $0.376B 0.00
Translate Bio (TBIO) United States $0.375B 0.00
Aptorum Group (APM) China $0.373B 0.00
Majesco Entertainment (PTE) United States $0.335B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.332B 0.00
Minerva Neurosciences (NERV) United States $0.322B 0.00
Lannett Co Inc (LCI) United States $0.322B 2.99
CASI Pharmaceuticals (CASI) United States $0.310B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.306B 0.00
HARPOON THERAPT (HARP) United States $0.288B 0.00
Dermira (DERM) United States $0.288B 0.00
Karyopharm Therapeutics (KPTI) United States $0.287B 0.00
Mast Therapeutics (SVRA) United States $0.285B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.261B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.259B 9.60
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.250B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.244B 0.00
Tyme Technologies (TYME) United States $0.239B 0.00
Opexa Therapeutics (ACER) United States $0.232B 0.00
Aclaris Therapeutics (ACRS) United States $0.230B 0.00
Jounce Therapeutics (JNCE) United States $0.227B 0.00
Aldeyra Therapeutics (ALDX) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
ElectroCore (ECOR) United States $0.215B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.213B 0.00
Molecular Templates (MTEM) United States $0.209B 0.00
Ardelyx (ARDX) United States $0.207B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.207B 0.00
IMV INC (IMV) Canada $0.205B 0.00
Recro Pharma (REPH) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.196B 203.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.179B 0.00
Ocular Therapeutix (OCUL) United States $0.173B 0.00
Aquestive Therapeutics (AQST) United States $0.162B 0.00
Neon Therapeutics (NTGN) United States $0.159B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.155B 0.00
Cardiome Pharma (CORV) Canada $0.150B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.144B 0.00
China SXT Pharmaceuticals (SXTC) China $0.142B 0.00
MediWound (MDWD) Israel $0.141B 0.00
ProNAi Therapeutics (SRRA) Canada $0.139B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.128B 0.00
DURECT (DRRX) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
Adherex Technologies (FENC) United States $0.116B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.113B 0.00
Zafgen (ZFGN) United States $0.112B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
Natural Alternatives (NAII) United States $0.088B 8.63
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Otonomy (OTIC) United States $0.086B 0.00
Genocea Biosciences (GNCA) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.076B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.062B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
Capnia (SLNO) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Melinta Therapeutics (MLNT) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
KemPharm (KMPH) United States $0.054B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.045B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
Achaogen (AKAO) United States $0.036B 0.00
NOVAN INC (NOVN) United States $0.030B 0.00
ContraFect (CFRX) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 0.00
HANCOCK JAFFE (HJLI) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.025B 0.00
ESSA Pharma (EPIX) Canada $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Xenetic Biosciences (XBIO) United States $0.021B 0.00
Achieve Life Sciences (ACHV) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Shineco (TYHT) China $0.015B 2.60
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Intellipharmaceutics (IPCI) Canada $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00